Effects of Dietary n-3 Fatty Acid Supplementation in Men with Weight Loss Associated with the Acquired Immune Deficiency Syndrome: Relation to Indices of Cytokine Production

Journal of Acquired Immune Deficiency Syndromes

Volumn 11, Issue 3, 1996, Pages 258-270

  Hellerstein, Marc K ^a,b,d   Wu, Kenneth ^a   McGrath, Michael ^b   Faix, Dennis ^a   George, Dianne ^b   Shackleton, Cedric H L ^c   Horn, William ^b   Hoh, Rebeccah ^b   Neese, Richard A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL OAKLAND   (United States)

^d SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FISH OIL; INTERFERON; INTERLEUKIN 1; OMEGA 3 FATTY ACID; TUMOR NECROSIS FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANOREXIA; ARTICLE; CLINICAL ARTICLE; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; FOOD INTAKE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRIGLYCERIDEMIA; IMMUNE DEFICIENCY; LIPOGENESIS; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; WEIGHT REDUCTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; APPETITE; CYTOKINES; FATTY ACIDS, OMEGA-3; FISH OILS; FOOD, FORTIFIED; HUMANS; INTERLEUKIN-1; LEUKOCYTES, MONONUCLEAR; LIPIDS; LIVER; MALE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 0029864955     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199603010-00006     Document Type: Article

References (72)

1. Kotler DP, Wang J, Pierson RN. Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 1985;42:1255-65.
2. Hellerstein MK, Kahn J, Mudie H, Viteri F. Current approach to the treatment of HIV associated weight loss: pathophysiologic considerations and a preliminary report on a double-blind placebo-controlled trial of megestrol acetate. Semin Oncol 1990;17(Suppl 9): 17-33.
3. Kotler DP, Tierney AR, Wang J, Pierson RN. Magnitude of body-cell mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989;50:444.
4. Serwadda D, Sewankambo NK, Carswell JW, et al. Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet 1985;2:849-52.
5. Kotler DP, Tierney AR, Culpeppermorgan JA, Wang J, Pierson RN. Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome. J Ent Parent Nutr 1990;14:454-8.
6. Conn S, Vartsky D, Vaswani AN, et al. Changes in body composition of cancer patients following combined nutritional support. Nutr Cancer 1982;4:107-19.
7. Shike M, Russell DMcR, Detsky AS, et al. Changes in body composition in patients with small cell lung cancer. The effect of total parenteral nutrition as an adjunct to chemotherapy. Ann Intern Med 1984;101:303-9.
8. Gillin JS, Shike M, Alcock N, et al. Malabsorption and mucosal abnormalities of the small intestine in the acquired immunodeficiency syndrome. Ann Intern Med 1985;102: 619-22.
9. Grunfeld C, Feingold K. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med 1992;327:329-37.
10. Grunfeld C, Pang L, Shimazu L, Shigenaga JK, Jensen P, Feingold KR. Resting energy expenditure, caloric intake and short-term weight change in human immunodeficiency virus infection and in acquired immunodeficiency syndrome. Am J Clin Nutr 1992;55:455-60.
11. Melchior JD, Salmon D, Ragaud D, et al. Resting energy expenditure is increased in stable malnourished HIV-infected patients. Am J Clin Nutr 1991;53:437-41.
12. Hommes M, Romijn JA, Endert E, Sauerwein HP. Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage. Am J Clin Nutr 1991;54:311-5.
13. Grunfeld C, Kotler DP, Hamadeh R, Tierney A, Wong J, Pierson RN. Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1989;86:27-31.
14. Hellerstein MK, Grunfeld C, Wu K, Christiansen M, Kaempfer S, Kletke C, Shackleton CHL. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab 1993;76:559-65.
15. Hellerstein MK. Lean body wasting and therapeutic implications of altered metabolism in AIDS. HIV: Advan Res Therapy 1993;3(3):8-16.
16. Mulligan K, Grunfeld C, Hellerstein MK, Neese R, Schambelan M. Anabolic effects of recombinant growth hormone in patients with weight loss associated with HIV infection. J Clin Endocrinol Metab 1993;77:956-62.
17. Beutler B, Cerami A. Cachetin: more than a tumor necrosis factor. N Engl J Med 1987;316:379-85.
18. Oliff A, Defeo-Jones D, Boyer M, et al. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 1987; 50:555-63.
19. Tracey KJ, Wei H, Manogue K, Kuo G, Lowry SF, Cerami A. Weight loss, cachexia and inflammation in rats treated with recombinant cachectin. J Exp Med 1988;167:1211-27.
20. Hellerstein MK, Meydani S, Meydani M, Wu K, Dinarello CA. Interleukin-1 anorexia in the rat: influence of prostaglandins. J Clin Invest 1989;83:228-35.
21. McCarthy DO, Kluger MJ, Vander AJ. Suppression of food intake during infections: is interleukin-1 involved? Am J Clin Nutr 1985;42:1179-82.
22. Patton JS, Peters PM, McCabe J, Crase D, Hansen S, Chen AB, and Liggit D. Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-α in rodents. J Clin Invest 1987;80:1587-96.
23. Feingold K, Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest 1987;80:184-90.
24. Blackham M, Cesar D, Park O-J, et al. Effects of recombinant monokines on hepatic pyruvate dehydrogenase (PDH), PDH kinase, de novo lipogenesis and plasma triglycerides. Abolition by prior fasting. Biochem J 1992;284:129-35.
25. Flores EA, Bistrian BR, Pomposelli JJ, Dinarello CA, Blackburn GL, Istfan NW. Infusion of tumor necrosis factor/ cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin-1. J Clin Invest 1989;83:1614-22.
26. Otterness IG, Seymour PA, Golden HW, Reynolds JA, Daumy GO. The effects of continuous administration of murine interleukin-1 alpha in the rat. Physiol Behav 1988;43: 797-804.
27. Mrosovsky N, Molony LA, Conn CA, Kluger MJ. Anorexic effects of interleukin-1 in the rat. Am J Physiol 1989;257: R1315-21.
28. Grunfeld C, Kotler DP, Shigenaga JK, et al. Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1991;90:154-62.
29. Lahdevirta J, Maury CPJ, Teppo AM, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988;85:289-91.
30. Roux-Lombard P, Modoux C, Cruchaud A, Doyer J-M. Purified blood monocytes from HIV-1 infected patients produce high levels of TNF-α and IL-1. Clin Immunol Immunopathol 1989;50:374-84.
31. Lau A, Livesay JF. Endotoxin induction of tumor necrosis factor is enhanced by acid-labile interferon-α in acquired immunodeficiency syndrome. J Clin Invest 1989;84:738-43.
32. Molina JM, Scadden DT, Byrn R, Dinarello CA, Groopman JE. Production of tumor necrosis factor α and interleukin 1-β by monocytic cells infected with human immunodeficiency virus. J Clin Invest 1989;84:733-7.
33. Munis JR, Richman DD, Kornbluth RS. Human immunodeficiency virus-1 infection of macrophages in vitro neither induces tumor necrosis factor (TNF)/cachectin gene expression nor alters TNF/cachectin induction by lipopolysaccharide. J Clin Invest 1990;85:591-6.
34. Molina J-M, Schindler R, Ferriani R, Sakaguchi M, Vannier E, Dinarello CA, Groopman J. Production of cytokines by peripheral blood monocytes/macrophage s infected with human immunodeficiency virus type 1 (HIV-1). J Infect Dis 1990;161:888-93.
35. Dinarello CA, Marnoy SO, Rosenwasser LJ. Role of arachidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte-activating factor/ interleukin 1. J Immunol 1983;130:890-5.
36. Tisdale MJ, Dhesi JK. Inhibition of weight loss by W-3 fatty acids in an experimental cachexia model. Cancer Res 1990; 50:5022-6.
37. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989;320:265-71.
38. Hellerstein MK, Christiansen M, Kaempfer S, et al. Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J Clin Invest 1991;87:1841-52.
39. Hellerstein MK, Kletke C, Kaempfer S, Wu K, Shackleton CHL. Use of mass isotopomer distributions in secreted lipids to sample lipogenic acetyl-CoA pool in vivo in humans. Am J Physiol 1991;261:E479-86.
40. Faix D, Neese RA, Kletke C, et al. Quantification of periodicities in menstrual and diurnal rates of cholesterol and fat synthesis in humans. J Lipid Res 1993;34:2063-75.
41. Hellerstein MK, Wu K, Kaempfer S, Kletke C, Shackleton CHL. Sampling the lipogenic hepatic acetyl-CoA pool in vivo in the rat. Comparison of xenobiotic probe to values predicted from isotopomeric distribution in circulating lipids and measurement of lipogenesis and acetyl-CoA dilution. J Biol Chem 1991;266:10912-9.
42. Hoffman-Goetz L, Kluger MJ. Protein deficiency: its effects on body temperature in health and disease states. Am J Clin Nutr 1979;32:1423-7.
43. Protein malnutrition and leukocyte endogenous mediator [Editorial]. Nutr Rev 1983;41:242-4.
44. Schattner A, Lachmi M, Livneh A, et al. Tumor necrosis factor in familial Mediterranean fever. Am J Med 1991;90: 434-8.
45. Molina J-M, Scadden DT, Amirault C, Woon A, Vannier E, Dinarello CA, Groopman JE. Human immunodeficiency virus does not induce interleukin-1, interleukin-6 or tumor necrosis factor in mononuclear cells. J Virol 1990;64:2901-6.
46. Meltzer MS, Skillman DR, Hoover DL, et al. Macrophages and the human immunodeficiency virus. Immunol Today 1990;11:217-23.
47. Meltzer MS, Skillman DR, Gomatos PJ, Kalter DC, Gendelman HE. Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. Annu Rev Immunol 1990;8:169-94.
48. Hellerstein MK, Hoh R, Neese R, et al. Effects of nutritional supplements of different composition on nutritional status and gut histology in HIV wasting: metabolic abnormalities for prediction of nutrient unresponsivity. In: VIIIth Proceedings of the International Conference on AIDS, Vol. 2. Amsterdam: Congrex Holland, 1992;B207.
49. Schwarz J-M, Neese R, Shackleton CHL, Hellerstein MK. De novo lipogenesis (DNL) during fasting and oral fructose in lean and obese hyperinsulinemic subjects [Abstract]. Diabetes 1993;42(Suppl 1):39A.
50. Neese RA, Benowitz NL, Hoh R, et al. Metabolic interactions between surplus dietary energy intake and cigarette smoking or its cessation. Am J Physiol 1994;267:E1023-34.
51. Hellerstein MK, Schwarz J-M, Neese RA, et al. De novo hepatic lipogenesis (DNL) is a highly sensitive biomarker of energy balance in controlled dietary conditions in normal humans. Diabetes 1994;43(Suppl 1):48.
52. Schwartz J-M, Neese RA, Turner S, Dare D, Hellerstein MK. Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis lipolyses, and whole body full selection. Clin Res (in press).
53. Schwarz J-M, Neese RA, Turner SM, Nguyen C, Hellerstein MK. Effect of fructose ingestion on glucose production (GP) and de novo lipogenesis (DNL) in normal and hyperinsulinemic obese humans. Diabetes 1994;43(Suppl 1):52A.
54. Hellerstein MK. Methods for measurement of fatty acid and cholesterol metabolism. In: Howard B, Packard C, eds. Curr Opin Lipidol 1995;6:172-81.
55. Hellerstein MK, Schwartz J-M, Neese RA. Regulation of hepatic de novo Hpogenesis in humans. Ann Rev Nutr 1996
56. Hommes MJT, Romijn JA, Endert E, Sauerwein HP. Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage. Am J Clin Nutr 1991;54:311-5.
57. Preble OT, Rothko K, Klippel JH, et al. Interferon-induced 2′-5′ adenylate synthase in vivo and interferon production in vitro from systemic lupus erythematosis patients with and without circulating interferon, J Exp Med 1983;157:2140-6.
58. Magilavy DB, Rothstein JL. Spontaneous production of tumor necrosis factor-alpha by Kupffer cells of MRI/lpr mice. J Exp Med 1988;168:789-94.
59. Kist A, Ho AD, Rath V, et al. Decrease of natural killer cell activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factor. Blood 1988;72:344-8.
60. Ritchie DG. Interleukin-6 stimulates hepatic glucose release from prelabeled glycogen pools. Am J Physiol 1990;258: E57-64.
61. Grunfeld C, Adi S, Soued M, Moser A, Fiers W, Feingold K. Search for mediators of the lipogenic effects of tumor necrosis factor: potential role for interleukin-6. Cancer Res 1990; 50:4233-8.
62. Strieter RM, Romcek DG, Ward PA, Spengler RN, Lynch JP, Larrick J, Kunkel SL. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun 1988;155:1230-6.
63. Dezube BJ, Eder JP, Pardee AB. Phase I of trial of escalating pentoxifylline dose with constant dose thalidomide. Cancer Res 1990;50:6808-10.
64. Sampaio EP, Sarno EN, Galilly R, Conn ZA, Kaplan G. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 1991;173:699-703.
65. Nestel PJ, Conner WE, Rearden RF, Connor S, Wong S, Boston R. Suppression by diets rich in fish oil at very low density lipoprotein production in men. J Clin Invest 1984; 74:82-9.
66. Daggy B, Drost C, Bensadoun A. Dietary fish oil decreases VLDL production rates. Biochim Biophys Acta 1987;920: 293-300.
67. Topping DL, Trimble RP, Storer GB. Failure of insulin to stimulate lipogenesis and triacylglycerol secretion in perfused livers from rats adapted to dietary fish oil. Biochim Biophys Acta 1987;927:423-8.
68. Macallan D, Noble C, Baldwin C, Foskett M, McManus T, Griffin GE. Prospective analysis of patterns of weight change in stage IV HIV infection. Am J Clin Nutr 1993;58:417-24.
69. Macallan DC, Noble C, Baldwin C, et al. The energetic basis of the HIV wasting syndrome. N Engl J Med 1995;333:83-8.
70. Grunfeld C, Pang M, Doerrler W, Shigenaga J, Jensen P, Feingold KR. Lipids, lipoproteins, triglyceride clearance and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992;74:1045-52.
71. Grunfeld C, Wilking H, Neese R, et al. Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphyllaxis to the anorectic/cachectic effects in rats. Cancer Res 1989;49:2554-60.
72. Dunbar J. Predictors of patients adherence: patient characteristics. In: Shumaker SA, Shron E, Ockene JK, et al., eds. The handbook of health behavior change, New York: Springer, 1990:348-60.